Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation

OncoImmunology

Volumn 1, Issue 9, 2012, Pages 1655-1657

  Gerlini, Gianni ^a   Di Gennaro, Paola ^b   Borgognoni, Lorenzo ^a  

^a SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cancer immunity; Cancer immunotherapy; Dendritic cells; Electrochemotherapy; Melanoma

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMIQUIMOD; INTERLEUKIN 10; INTERLEUKIN 2; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; TRANSFORMING GROWTH FACTOR BETA; TUMOR ANTIGEN;

CANCER IMMUNOTHERAPY; CELL ACTIVATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ELECTROCHEMOTHERAPY; HUMAN; IN VIVO STUDY; INFLAMMATORY INFILTRATE; LANGERHANS CELL; MELANOMA; NOTE; PRIORITY JOURNAL; TH1 CELL; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT;

EID: 84879156920     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.21991     Document Type: Note

References (10)

1. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007; 449:419-26
2. Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells. Nat Rev Cancer 2012; 12:265-77
3. Stoitzner P, Green LK, Jung JY, Price KM, Tripp CH, Malissen B, et al. Tumor immunotherapy by epicutaneous immunization requires langerhans cells. J Immunol 2008; 180:1991-8
4. Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, et al. Electrochemotherapy-An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer 2006; 4:3-13.
5. Roux S, Bernat C, Al-Sakere B, Ghiringhelli F, Opolon P, Carpentier AF, et al. Tumor destruction using electrochemotherapy followed by CpG oligodeoxynucleotide injection induces distant tumor responses. Cancer Immunol Immunother 2008; 57:1291-300
6. Gerlini G, Sestini S, Di Gennaro P, Urso C, Pimpinelli N, Borgognoni L. Dendritic cells recruitment in melanoma metastasis treated by electrochemotherapy. Clin Exp Metastasis 2012; In Press
7. Drobits B, Holcmann M, Amberg N, Swiecki M, Grundtner R, Hammer M, et al. Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells. J Clin Invest 2012; 122:575-85
8. Min L, Mohammad Isa SA, Shuai W, Piang CB, Nih FW, Kotaka M, et al. Cutting edge: granulocyte-macrophage colony-stimulating factor is the major CD8+ T cell-derived licensing factor for dendritic cell activation. J Immunol 2010; 184:4625-9
9. Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363:711-23
10. Postow MA, Callahan MK, Barker CA, Yamada Y, Yuan J, Kitano S, et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med 2012; 366:925-31